Several Marshall University representatives are among more than 20 life science experts who will share experiences and discuss strategies for successfully growing the state’s bioscience industry during the upcoming West Virginia Bioscience Summit.
Sponsored by the Bioscience Association of West Virginia (BioWV), the summit will take place from 8 a.m. to 4:30 p.m. Thursday, Feb. 28, at the Marriott Town Center in Charleston. The annual event brings together members of the state’s bioscience community with policy and opinion leaders, economic developers and others who are interested in learning more about how to grow and nurture the industry.
At the summit, Dr. John Maher, Marshall vice president for research, will join representatives from the Blanchette Rockefeller Neurosciences Institute, West Virginia State University, the University of Charleston and West Virginia University on a panel highlighting research being conducted in the state.
“The BioWV Summit is a tremendous opportunity to bring attention to the significant economic development happening via West Virginia’s life sciences community,” said Maher. “At the other end of the pipeline we have a great deal of exciting biotechnology work happening here at Marshall and we are pleased to have this chance to share it with our colleagues and friends from around the state and region.”
Dr. Nader Abraham, vice dean for research at the Joan C. Edwards School of Medicine, is on the program to share information about clinical trials at Marshall, and the assistant director of Marshall’s Technology Transfer Office, Amy Melton, will participate in a panel discussion about commercialization opportunities and recent changes in U.S. patent law.
In addition, representatives of two Marshall spinout companies, Derek Gregg of Vandalia Research and Dr. Pier Paolo Claudio of Cordgenics, are scheduled to be on a panel of bioscience company representatives and funders who will discuss the challenges of raising capital and creating an environment for life science growth in the state. Gregg and Claudio both founded their companies on technology they developed in the university’s labs.
A host of industry leaders, policy-makers and other experts also will participate in the conference, including the following:
- Governor Earl Ray Tomblin (invited);
- Fritz Bittenbender, Vice President, Alliance Development and State Government Relations, Biotechnology Industry Organization (BIO);
- Jeff May, Vice President, Product Strategy, Mylan North America;
- Dr. Paul Hill, Chancellor, West Virginia Higher Education Commission;
- Jeff Trewhitt, Senior Director of Communications and Public Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA).
The summit’s keynote speaker will be Dr. David Scholl, who helped grow Athens, Ohio-based Diagnostic Hybrids into a $100 million biotech company. He is now a partner in a regional venture capital firm and is involved with the billion-dollar Ohio Third Frontier program.
Gregg, who serves as the chairman of BioWV, said, “A successful life science industry begins with research, which then leads to discoveries. Those discoveries provide the basis for company development and economic growth for the state. West Virginia is having success but there is much more that can be done to help grow this industry within our borders.
“The bioscience industry is creating new technologies—pharmaceuticals, diagnostics, medical technologies, chemical processes and more—that not only advance science but provide high-wage jobs to West Virginia residents. This conference will bring people together to highlight what is currently under way and to discuss how we can grow the industry.”
Marshall University is a founding member of BioWV. The purpose of the association is to promote and strengthen the bioscience industry in the state by developing a cohesive community that unites biotechnology, pharmaceutical, medical device and research organizations.
For more information or to register for the summit, visit www.biowv.org.